Riskpilot← Back to searchSign inGet full accessDario vård AB
ABActiveOrg 5568288426Strandvägen 19 A Lgh 1201General medical practice activities · NACE 8621Est. 20102 employees
Revenue 2024
SEK 3,5M
+13% vs 2023
EBITDA margin
21.6%
-20% vs 2023
Equity ratio
60.4%
Financial strength
Net profit 2024
SEK 440K
-14% vs 2023
| Revenue | SEK 3,5M | +13% |
| EBITDA | SEK 763K | -20% |
| Net profit | SEK 440K | -14% |
| Total assets | SEK 2,4M | +20% |
| Equity | SEK 1,4M | +28% |
| Employees | 2 | — |
Legal name
Dario vård AB
Org number
5568288426
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 december 2010
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva allmänmedicin, rehabilitering, habilitering, psykiatri med sluten och öppen vård, behandlingar, vård av särskilt utsatta grupper, lungmedicin, invärtes medicin, export och försäljning av sjukvårdsutrustning samt därmed förenlig verksamhet.
Address
Strandvägen 19 A Lgh 1201
Email
shohreh_salehpour@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 492 | 2 300 | 2 756 | 3 129 | 3 537 |
| Staff expenses | — | — | −1 416 | −1 622 | −1 902 |
| EBITDA | 259 | 444 | 850 | 955 | 763 |
| Depreciation & amort. | −0 | −0 | −226 | −237 | −221 |
| EBIT | 259 | 444 | 624 | 718 | 542 |
| Net financials | −1 | −11 | −14 | −5 | −3 |
| Profit before tax | 258 | 325 | 458 | 554 | 567 |
| Tax | −55 | −67 | −94 | −40 | −127 |
| Net profit | 203 | 258 | 364 | 513 | 440 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 545 | 1 212 | 1 545 | 1 993 | 2 396 |
| Equity | 291 | 549 | 712 | 1 126 | 1 446 |
| Long-term debt | 0 | 166 | 50 | 0 | — |
| Short-term debt | 233 | 369 | 501 | 425 | 537 |
| Total debt | 233 | 535 | 551 | 425 | 537 |
EBITDA margin
21.6%
This company
15.8%
Market median
+37% vs market
20202024
Equity ratio
60.4%
This company
38.2%
Market median
+58% vs market
20202024
Return on equity
30.4%
This company
18.4%
Market median
+65% vs market
20202024
Net profit margin
12.5%
This company
8.1%
Market median
+54% vs market
20202024
Asset turnover
1.48×
This company
1.12×
Market median
+32% vs market
20202024
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dario vård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Shohreh Salehpour | Board of Directors | 0 companies |
| Shahla Salhpour | Deputy Board Member | 0 companies |